{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:19:10Z","timestamp":1759580350793},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["STEM CELLS"],"published-print":{"date-parts":[[1995,1]]},"DOI":"10.1002\/stem.5530130203","type":"journal-article","created":{"date-parts":[[2009,6,15]],"date-time":"2009-06-15T14:48:09Z","timestamp":1245077289000},"page":"112-122","source":"Crossref","is-referenced-by-count":3,"title":["rHuGM\u2010CSF after high\u2010dose chemotherapy in post\u2010remission acute leukemia"],"prefix":"10.1093","volume":"13","author":[{"given":"Rafael","family":"Hurtado","sequence":"first","affiliation":[{"name":"Departament of Hemato\u2010Oncology, Instituto Nacional de la Nutricion, Salvador Zubiran, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrna","family":"Candelaria","sequence":"additional","affiliation":[{"name":"Departament of Hemato\u2010Oncology, Instituto Nacional de la Nutricion, Salvador Zubiran, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florencia","family":"Vargas","sequence":"additional","affiliation":[{"name":"Departament of Hemato\u2010Oncology, Instituto Nacional de la Nutricion, Salvador Zubiran, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Majluf","sequence":"additional","affiliation":[{"name":"Departament of Hemato\u2010Oncology, Instituto Nacional de la Nutricion, Salvador Zubiran, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Bola\u00f1os","sequence":"additional","affiliation":[{"name":"Departament of Hemato\u2010Oncology, Instituto Nacional de la Nutricion, Salvador Zubiran, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan R.","family":"Labardini","sequence":"additional","affiliation":[{"name":"Departament of Hemato\u2010Oncology, Instituto Nacional de la Nutricion, Salvador Zubiran, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,12,23]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"47","volume-title":"Hematology\/Oncology Clinics of North America","author":"Stone R","year":"1993"},{"key":"e_1_2_1_3_2","first-page":"1","article-title":"Treatment of acute lymphoblastic leukemia","volume":"31","author":"Hoeltzer D","year":"1994","journal-title":"Semin Hematol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb03203.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530120301"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.2.596.596"},{"issue":"1","key":"e_1_2_1_7_2","first-page":"16a","article-title":"Recombinant human granulocyte\/monocyte colony\u2010stimulating factor (rHuGM\u2010CSF) for the treatment of bone marrow (BM) aplasia in accidentally irradiated (60 Co) patients (pts). Report of three cases","volume":"74","author":"Hurtado\u2010Monroy R","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood.V83.2.610.610","article-title":"High dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte\u2010macrophage colony stimulating factor on the autograft","volume":"83","author":"Bishop MR","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198804073181401"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92961-3"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood.V77.2.211.211","article-title":"The evolving role of autologous peripheral stem\u2010cell transplantation following high\u2010dose therapy for malignancies","volume":"77","author":"Kessinger A","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_12_2","first-page":"255","volume-title":"Hematology\/Oncology Clinics of North America","author":"Bernstein SH","year":"1993"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood.V69.6.1551.1551","article-title":"Acute myelogenous leukemia","volume":"69","author":"Champlin RE","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood.V58.6.1203.1203","article-title":"Treatment of acute myelocytic leukemia: a study by the Cancer and Leukemia Group B","volume":"58","author":"Rai KR","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_15_2","first-page":"1441","article-title":"Comparison of three remission\u2010induction regimens and two post\u2010induction strategies for the treatment of acute non\u2010lymphocytic leukemia: a cancer and leukemia Group B study","volume":"69","author":"Preisler H","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1182\/blood.V77.7.1429.1429","article-title":"High dose cytarabine and daunorubicin induction and post\u2010remission chemotherapy for the treatment of acute myelogenous leukemia in adults","volume":"77","author":"Phillips GL","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V77.8.1666.1666","article-title":"Results of a randomized trial comparing idarubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia","volume":"77","author":"Berman E","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V75.1.27.27","article-title":"For the Australian Leukemia Study Group. Etoposide in acute nonlymphocytic leukemia","volume":"75","author":"Bishop JP","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V60.2.454.454","article-title":"Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a Cancer and leukemia Group B study","volume":"60","author":"Yates J","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_20_2","first-page":"856a","article-title":"A randomized investigation of high\u2010dose (HIDAC) vs. standard dose (SDAC) cytosine arabinoside with daunorubicin (DNR) in patients with acute myelogenous leukemia","volume":"11","author":"Weick J","year":"1992","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_21_2","first-page":"849a","article-title":"Randomized trial of high dose cytosine arabinoside (Ara\u2010c) combination in induction in acute myeloid leukemia (AML)","volume":"11","author":"Bishop JF","year":"1992","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198008283030901"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1974.tb06805.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-94-6-753"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90858-0"},{"issue":"4","key":"e_1_2_1_26_2","first-page":"65","article-title":"Prognostic factors for selecting curative therapy for adult acute myeloid leukemia","volume":"6","author":"Bloomfield CD","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_1_27_2","first-page":"177","volume-title":"Hematology\/Oncology Clinics of North America","author":"Christiansen NP","year":"1993"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403243301206"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.1.226"},{"key":"e_1_2_1_30_2","first-page":"94","article-title":"Hematopoietic colony\u2010stimulating factors and dose intensity","volume":"20","author":"Petros P","year":"1993","journal-title":"Semin Oncol"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.4.661"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1200\/JCO.1994.12.4.650","article-title":"Did we focus on the most important issues in the use of growth factors and stem\u2010cell transplantation?","volume":"12","author":"Gulati SC","year":"1994","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-3-183"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood.V73.3.849.849","article-title":"In vivo administration of recombinant human granulocyte\/macrophage colony\u2010stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts","volume":"73","author":"Blazer BR","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1685"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199243040-00008"},{"key":"e_1_2_1_37_2","first-page":"131","article-title":"Recombinant human GM\u2010CSF following chemotherapy in high\u2010risk AML","volume":"6","author":"B\u00fcechner T","year":"1990","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_1_38_2","first-page":"732","article-title":"Treatment of poor prognostic, newly diagnosed acute myelogenous leukemia with high\u2010dose cytarabine (Ara\u2010C) and rHuGM\u2010CSF","volume":"33","author":"Estey EH","year":"1990","journal-title":"Haematol Blood Transfus"},{"issue":"1","key":"e_1_2_1_39_2","first-page":"457a","article-title":"Intermediate dose Ara\u2010C (IDAC) and VP\u201016 regimen plus recombinant human granulocyte macrophage\u2010colony stimulating factor rescue (rHuGM\u2010CSF) for resistant (RES) and relapsed (REL) adult acute leukemia (ALL)","volume":"80","author":"Hurtado MR","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V67.5.1448.1448"},{"key":"e_1_2_1_41_2","first-page":"328","article-title":"Granulocyte\u2010macrophage colony\u2010stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia","volume":"3","author":"Cannistra SA","year":"1989","journal-title":"Leukemia"},{"issue":"1","key":"e_1_2_1_42_2","first-page":"127","article-title":"GM\u2010CSF in combination with cytotoxic chemotherapy in AML patients","volume":"6","author":"Bettelheim P","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_43_2","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1182\/blood.V78.5.1190.1190","article-title":"Recombinant granulocyte\u2010macrophage colony stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse","volume":"78","author":"B\u00fcchner T","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.9.2246.2246"},{"issue":"1","key":"e_1_2_1_45_2","first-page":"1299a","article-title":"Phase III randomized placebo\u2010controlled study of granulocyte macrophage colony\u2010stimulating factor (GM\u2010CSF) in adult patients (55\u201370 years) with acute myelogenous leukemia (AML). A study of the Eastern Cooperative Group (ECOG)","volume":"10","author":"Rowe J","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.9.1260"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940701)74:1<52::AID-CNCR2820740110>3.0.CO;2-G"},{"key":"e_1_2_1_48_2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1200\/JCO.1990.8.7.1199","article-title":"Post\u2010remission chemotherapy for adults with acute myelogenous leukemia: improved survival with high\u2010dose cytarabine and daunorubicin consolidation treatment","volume":"8","author":"Champlin R","year":"1990","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.9.1260"},{"key":"e_1_2_1_50_2","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1182\/blood.V77.7.1429.1429","article-title":"High dose cytarabine and daunorubicin induction and post\u2010remission chemotherapy for the treatment of acute myelogenous leukemia in adults","volume":"77","author":"Phillips GL","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_51_2","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V80.12.2977.2977","article-title":"Long term outcome of high dose cytarabine\u2010based consolidation chemotherapy for adults with acute myelogenous leukemia","volume":"80","author":"Schiller G","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_52_2","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood.V79.8.1924.1924","article-title":"Varying intensity of post\u2010remission therapy in acute myeloid leukemia","volume":"79","author":"Cassileth PA","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_53_2","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1200\/JCO.1993.11.9.1636","article-title":"Post\u2010remission therapy for the younger adult patient with acute myelogenous leukemia. Defining a role for transplantation","volume":"11","author":"Hurd DD","year":"1993","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_54_2","first-page":"853a","article-title":"Comparative evaluation of intensive postremission therapy with different dose schedules of Ara\u2010C in adults with acute myeloid leukemia (AML): initial results of a CALGB phase III study","volume":"11","author":"Mayer RJ","year":"1992","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_55_2","first-page":"724","article-title":"Recombinant human granulocyte\u2010macrophage colony stimulating factor after chemotherapy for acute leukemias at higher age or after relapse","volume":"33","author":"B\u00fcchner T","year":"1990","journal-title":"Haematol Blood Transfus"},{"key":"e_1_2_1_56_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood.V76.3.473.473","article-title":"High\u2010dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy","volume":"76","author":"Brown RA","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04867.x"},{"issue":"1","key":"e_1_2_1_58_2","first-page":"55a","article-title":"Relationship of invasive fungal disease and high dose cytarabine plus etoposide containing remission\u2010induction regimens for acute myeloid leukemia","volume":"78","author":"Bow EJ","year":"1991","journal-title":"Blood"},{"issue":"1","key":"e_1_2_1_59_2","first-page":"56a","article-title":"Adult acute lymphoblastic leukemia (AALL) comparison of weekly doxorubicin (WD) vs. three day schedule (TDS) for induction remission. Long\u2010term results","volume":"80","author":"Candelaria HM","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.5.813"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91969-6"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.9.1652"},{"key":"e_1_2_1_63_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood.V79.2.473.473","article-title":"Clinical significance of multidrug resistance P\u2010glycoprotein expression on acute nonlymphocytic leukemia cells at diagnosis","volume":"79","author":"Campos L","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_64_2","first-page":"64","article-title":"Drug resistance modulation in the laboratory and the clinic","volume":"20","author":"Dalton WS","year":"1993","journal-title":"Semin Oncol"},{"key":"e_1_2_1_65_2","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1182\/blood.V83.5.1337.1337","article-title":"Synergistic reversal of multidrug\u2010resistant phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL","volume":"83","author":"Ross DD","year":"1994","journal-title":"Blood"}],"container-title":["STEM CELLS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fstem.5530130203","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/stem.5530130203","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/stem.5530130203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T03:08:00Z","timestamp":1642561680000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/13\/2\/112-122\/6389932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["10.1002\/stem.5530130203"],"URL":"https:\/\/doi.org\/10.1002\/stem.5530130203","archive":["Portico"],"relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}